Copyright@2018 NANJING JIAYI SUNWAY CHEMICAL CO.LTD.  All rights reserved 苏ICP备15063822号 power by


The potential of the biomedical market is huge. Various regions have increased their support.

Page view
In recent years, China's bio-pharmaceutical industry has developed rapidly, and some institutions predict that China's bio-pharmaceutical market will reach 145.8 billion yuan in 2017

In recent years, China's bio-pharmaceutical industry has developed rapidly, and some institutions predict that China's bio-pharmaceutical market will reach 145.8 billion yuan in 2017, with huge market potential. It is reported that in recent years, China has also given various policies and financial support to promote the development of the biomedical industry.

For example, on August 12, at the final of the 7th China Innovation and Entrepreneurship Competition (Guangzhou Division) biomedical industry, as many as 82 biomedical innovation companies competed for a million yuan subsidy and venture capital support. The “Creator China” big health double-creation competition that successfully closed in Guangzhou recently brought more than 7 million yuan of resources to 25 excellent medical projects. The author was informed that in the context of the rapid development of the biomedical industry, many regions are increasing their support for biomedicine.

Shanghai released policy to further promote the sustainable development of biomedical industry in Minhang District

Recently, Shanghai issued the “Implementation Opinions of the General Office of the Shanghai Municipal People's Government on Promoting the Healthy Development of the Biomedical Industry of the City” (Shanghai Fufa [2017] No. 51) to further promote the sustainable development of the biomedical industry in Minhang District. It encourages biomedical related enterprises to carry out major industrial and technological research, and declares major industrial technology research projects in Minhang District.

Jiangxi Yinzhou boosts the development of biomedical industry

In recent years, Ganzhou City has promoted the development of bio-pharmaceutical industry with Qingfeng Pharmaceutical Valley as its core, introduced a series of measures to support the development of bio-pharmaceutical industry, and established a bio-medical industry development guiding fund of 1 billion yuan in innovation development, mergers and acquisitions, new drug approval and listing. All aspects support the development of the biopharmaceutical industry. Qingfeng Pharmaceutical Valley has formed five major sectors: manufacturing, medicinal planting, health, medical trade and public services. There are 22 projects under construction with a total investment of 5.13 billion yuan. At present, there are 24 large-scale pharmaceutical industrial enterprises in Ganzhou City. Last year, the main business income was 9.328 billion yuan, a year-on-year increase of 7.95%.

Guangzhou accelerates the development of biomedical industry

Guangzhou issued an implementation opinion to accelerate the development of the bio-pharmaceutical industry, pointing out that the bio-pharmaceutical industry is focusing on the high-end development of the value chain and innovation chain, and deepening the reform of the system and mechanism, optimizing government services, and innovative management methods as the starting point in all aspects of the industrial chain. Promote the concept change, mechanism improvement and capacity improvement, open up the global high-end innovation elements, promote the development of high-growth enterprises, guide the innovation and quality of large enterprises, and build Guangzhou into an important bio-pharmaceutical innovation city and have global influence. The biomedical health industry is a major town.

Chongqing actively promotes precision investment and accelerates the production of enterprises

Since the beginning of this year, Chongqing Biomedical Industrial Park has been promoting the promotion of precision investment and speeding up the production of enterprises. In order to accelerate the commissioning of enterprises, Chongqing Biomedical Industrial Park adopts an embedded, one-to-one, peer-to-peer approach, on-call, one-in-one policy, and personalized service to assist enterprises in solving problems such as formalities, construction organization, and factor protection. And problems, speed up the project to achieve production efficiency. In addition, in order to provide the optimal R&D environment for the settled enterprises, the park set up a scientific and technological innovation service center to continuously strengthen the enterprise innovation service work, actively assist enterprises to increase the approval of scientific research results, and declare innovative enterprises in the city and district to strive for special fund support for product research and development.